Your browser doesn't support javascript.
loading
Repeated mutKRAS ctDNA measurements represent a novel and promising tool for early response prediction and therapy monitoring in advanced pancreatic cancer.
Kruger, S; Heinemann, V; Ross, C; Diehl, F; Nagel, D; Ormanns, S; Liebmann, S; Prinz-Bravin, I; Westphalen, C B; Haas, M; Jung, A; Kirchner, T; von Bergwelt-Baildon, M; Boeck, S; Holdenrieder, S.
Afiliação
  • Kruger S; Department of Medicine III, University Hospital, LMU, Munich, Germany.
  • Heinemann V; Department of Medicine III, University Hospital, LMU, Munich, Germany.
  • Ross C; Sysmex Inostics, Hamburg, Germany.
  • Diehl F; Sysmex Inostics, Hamburg, Germany.
  • Nagel D; Institute of Laboratory Medicine, University Hospital, LMU, Munich, Germany.
  • Ormanns S; Institute of Pathology, LMU, Munich, Germany.
  • Liebmann S; Institute of Pathology, LMU, Munich, Germany.
  • Prinz-Bravin I; Institute of Clinical Chemistry and Clinical Pharmacology, University of Bonn, Bonn, Germany.
  • Westphalen CB; Department of Medicine III, University Hospital, LMU, Munich, Germany.
  • Haas M; Department of Medicine III, University Hospital, LMU, Munich, Germany.
  • Jung A; Institute of Pathology, LMU, Munich, Germany.
  • Kirchner T; Institute of Pathology, LMU, Munich, Germany.
  • von Bergwelt-Baildon M; Department of Medicine III, University Hospital, LMU, Munich, Germany.
  • Boeck S; Department of Medicine III, University Hospital, LMU, Munich, Germany.
  • Holdenrieder S; Institute of Clinical Chemistry and Clinical Pharmacology, University of Bonn, Bonn, Germany; Institute of Laboratory Medicine, German Heart Center, Technical University of Munich, Munich, Germany. Electronic address: holdenrieder@dhm.mhn.de.
Ann Oncol ; 29(12): 2348-2355, 2018 12 01.
Article em En | MEDLINE | ID: mdl-30346475

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Pancreáticas / Protocolos de Quimioterapia Combinada Antineoplásica / Biomarcadores Tumorais / Proteínas Proto-Oncogênicas p21(ras) / Desoxicitidina / DNA Tumoral Circulante Tipo de estudo: Evaluation_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Aged / Female / Humans / Middle aged Idioma: En Ano de publicação: 2018 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Pancreáticas / Protocolos de Quimioterapia Combinada Antineoplásica / Biomarcadores Tumorais / Proteínas Proto-Oncogênicas p21(ras) / Desoxicitidina / DNA Tumoral Circulante Tipo de estudo: Evaluation_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Aged / Female / Humans / Middle aged Idioma: En Ano de publicação: 2018 Tipo de documento: Article